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Abstract
Background: We previously identified a group of glucocorticoid-responsive genes, including Serum Glucocorticoid
kinase 1 (Sgk1), regulated by acute ethanol in prefrontal cortex of DBA2/J mice. Acute ethanol activates the
hypothalamic pituitary adrenal axis (HPA) causing release of glucocorticoids. Chronic ethanol dysregulates the HPA
response in both humans and rodents, possibly contributing to important interactions between stress and alcoholism.
Because Sgk1 regulates ion channels and learning and memory, we hypothesized that Sgk1 contributes to HPA-
dependent acute and adaptive neuronal responses to ethanol. These studies characterized acute and chronic
ethanol regulation of Sgk1 mRNA and protein and their relationship with ethanol actions on the HPA axis.
Results: Acute ethanol increased Sgk1 mRNA expression in a dose and time dependent manner. Three separate
results suggested that ethanol regulated Sgk1 via circulating glucocorticoids: acute ethanol increased glucocorticoid
receptor binding to the Sgk1 promoter; adrenalectomy blocked ethanol induction of Sgk1 mRNA; and chronic ethanol
exposure during locomotor sensitization down-regulated HPA axis activation and Sgk1 induction by acute ethanol.
SGK1 protein had complex temporal responses to acute ethanol with rapid and transient increases in Ser422
phosphorylation at 15 min. following ethanol administration. This activating phosphorylation had functional
consequences, as suggested by increased phosphorylation of the known SGK1 target, N-myc downstream-regulated
gene 1 (NDRG1). After repeated ethanol administration during locomotor sensitization, basal SGK1 protein
phosphorylation increased despite blunting of Sgk1 mRNA induction by ethanol.
Conclusions: These results suggest that HPA axis and glucocorticoid receptor signaling mediate acute ethanol
induction of Sgk1 transcription in mouse prefrontal cortex. However, acute ethanol also causes complex changes in
SGK1 protein expression and activity. Chronic ethanol modifies both SGK1 protein and HPA-mediated induction of
Sgk1 mRNA. These adaptive molecular responses of glucocorticoid-responsive gene expression and SGK1 in
prefrontal cortex may contribute to mechanisms underlying behavioral responses to chronic ethanol exposure.
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Introduction
Although alcohol dependence is a complex disease that
develops over many years and includes cycles of withdrawal,
craving, and relapse, acute responses to ethanol have
predictive validity in terms of risk for high levels of ethanol
intake in animal models and alcoholism in humans [1,2].
Therefore, defining the cellular mechanisms underlying acute
responses to ethanol has significant biomedical implications.
Ethanol acutely activates the hypothalamic adrenal pituitary
(HPA) axis leading to glucocorticoid release from the adrenal
glands [3]. Glucocorticoid hormones are the final step in
activation of the HPA axis and are known to function in the
biological response to stress and circadian activity [4,5].
Glucocorticoids are also well known to regulate gene
expression [6]. In alcohol dependence, the HPA axis is
dysregulated in both humans [7,8] and rodents [9–11], but the
consequences of this dysregulation remain unclear.
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Our laboratory and others have used genome-wide
expression profiling to identify gene networks functioning in
acute and chronic behavioral responses to ethanol [12–17]. We
previously identified a group of genes prominently regulated by
acute ethanol in the prefrontal cortex (PFC) of DBA2/J (D2)
mice [12]. Contained in this group were well-characterized
glucocorticoid responsive genes including FK506 binding
protein 5 (Fkbp5) and Serum Glucocorticoid Kinase 1 (Sgk1)
[18,19]. Sgk1 is a glucocorticoid responsive gene that regulates
ion channel function, cell survival, and is involved in synaptic
plasticity, learning and memory [20–24].
Sgk1 has multiple transcript and protein isoforms generated
though alternative promoter utilization, splicing, translation and
post-translational modifications [25,26]. It is known that there
are 5 isoforms of Sgk1—4 resulting from translational
processing of Sgk1 and one, Sgk1.1, resulting from alternative
promoter utilization and splicing [25,26]. Because Sgk1 is
regulated by both glucocorticoids and acute ethanol and is
known to regulate ion channel function and synaptic plasticity,
we hypothesized that Sgk1 signaling may be an important
mechanism underlying acute cellular responses to ethanol in
brain and might also play a role in behavioral adaptations with
chronic ethanol exposure. We have therefore performed a
detailed analysis on ethanol regulation of Sgk1 from the
transcriptional to protein level. Our results indicate a complex
regulation of Sgk1 transcription, protein abundance and post-
translational modification following acute and chronic ethanol
treatment.
Material and Methods
Ethics Statement
All procedures were approved by Virginia Commonwealth
University Institutional Animal Care and Use Committee under
protocol number AM10332 and followed the NIH Guide for the
Care and Use of Laboratory Animals (NIH Publications No. 80–
23, 1996).
Animals
Mice were maintained in a temperature-controlled room
(23°C±1) with 12 h light/dark cycles and free access to
standard chow (Harlan Teklad #7912, Madison, WI, United
States) and water. Cages and bedding (Harlan Sani-chips,
#7090A, Harlan, Teklad, Madison, WI, United States) were
changed weekly. All tests were carried out between 0900 and
1200 h. All mice were DBA2/J mice from Jackson Laboratories
(Bar Harbor, ME, United States) purchased at 10-13 weeks of
age and group housed 4/cage. Adrenalectomized (ADX) and
sham mice were treated at Jackson and delivered following
recovery from surgery. ADX mice were supplemented with 1%
w/v saline solution in their drinking water. All mice were allowed
to habituate to the animal facility for at least 1 week prior to
testing.
Adrenalectomy
All adrenalectomies and sham procedures were conducted
using aseptic and atraumatic surgical techniques at Jackson
Laboratories and were approved by the institution’s Animal
Care and Use Committee. According to documentation
provided by Jackson Laboratories, surgeries were performed
using the lateral abdominal approach. Left and right adrenal
glands were removed through separate incisions. The animals
were anesthetized using tribromoethanol, carprofen was
administered for analgesia and the surgical site was prepared.
The animals were placed in right lateral recumbency and a
5-8mm incision was made parallel and ventral to the spine and
midway between the last rib and iliac crest. The underlying
muscle was opened and the adrenal gland was located cranial
to the left kidney. The adrenal gland was grasped with ring
forceps and exteriorized. The adrenal and adjacent adipose
tissues were excised. The incisions in the abdominal wall and
skin were closed separately. Bupivacaine was applied topically
to the incision site for local analgesia. Skin closure material
was removed prior to shipment. The same procedure was
followed for excision of the right adrenal gland except the skin
incision was made immediately caudal to the last rib. This
adjustment was necessary to accommodate for the more
cranial location of the right adrenal gland relative to the left in
the abdomen. Surgeries were performed throughout the day
from 7: 30 am to 2:30 pm.
Drugs
All drugs were administered intraperitoneally (i.p.). Saline
solutions were 0.9% w/v sterile saline. Ethanol solutions were
prepared from 200-proof absolute anhydrous ethanol
(Pharmco-Aaper brand, Brookfield, CT, United States). Ethanol
was administered at 20% v/v in 0.9% saline.
Experimental Testing
Mice were habituated to injections with saline in their home
cage for 2 days prior to experimental testing. If behavioral
testing was performed, mice were allowed a 1-hour acclimation
period to the behavioral room prior to testing. All locomotor
activity was measured immediately following injection with
either saline or ethanol, during a 10-minute session in
locomotor activity chambers (Med-Associates, model ENV-515;
St. Albans, VT, United States).
Exp. 1 – Time course and dose response analysis of
Sgk1 and Sgk1.1 expression following acute ethanol
administration.  For the time course experiment, six groups of
mice (n = 4 each) were administered either saline or 4 g/kg
ethanol and groups of animals, one saline treated group and
one ethanol treated group, were harvested 2, 4 and 8 hours
following drug administration. For the dose response
experiment, three groups of mice (n = 8) were administered
saline, 2 g/kg ethanol or 4 g/kg ethanol and harvested 4 hours
following injection and brain micropunch dissections performed.
Exp. 2 – Sgk1 levels following ethanol
sensitization.  Animals (n = 4) received one of three
treatments: saline-saline (SS), saline-ethanol (SE) or ethanol-
ethanol (EE) (Table 1). On conditioning days 3-13, animals
received daily injections in their home cages of either saline
(SS, SE) or 2.5 g/kg ethanol (EE). On test day 14 the SS group
received saline and the SE and the EE groups received 2.0
g/kg ethanol and were placed in locomotor activity chambers
Ethanol Regulation of Sgk1
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for testing x 10 minutes. They were then returned to their home
cages and four hours following drug administration, brains were
harvested and brain micropunch dissections performed.
Exp. 3 – Corticosterone levels following ethanol
sensitization.  Animals (n=6) received one of four treatments:
saline-saline (SS), ethanol-saline (ES), saline-ethanol (SE) or
ethanol-ethanol (EE) (Table 1) with doses, schedules and
behavioral testing as with Exp. 2. One hour following the last
drug administration, animals were harvested and trunk blood
collection performed.
Exp 4 – Effects of ADX on Sgk1 induction following
ethanol administration.  ADX and Sham animals (n=11-15)
received either 4 g/kg ethanol or saline. Mice were harvested
four hours following ethanol or saline administration and brain
micropunch dissections performed for RNA isolation and Q-
rtPCR. To ensure that mice were in fact adrenalectomized, a
separate group of ADX and SHAM mice (n = 4-5) were
administered either saline or acute ethanol. One hour following
the last drug administration, animals were harvested and trunk
blood collection performed for determination of corticosterone
levels.
Exp. 5 – Glucocorticoid receptor binding to Sgk1
promoter following acute ethanol administration.  Mice (n =
8/group, 48 total) were treated with saline or 4 g/kg ethanol and
harvested via cervical dislocation 1 hour following drug
administration. Following cervical dislocation, the brain was
removed, the olfactory bulbs were separated from the brain
and a cut was made just rostral to the optic chiasm to collect
the frontal pole of the brain. Tissue was then processed for
DNA or chromatin isolation for chromatin immunoprecipiation
(ChIP) assays.
Exp. 6 – SGK1 phosphoSerine (S422) and SGK1 Levels
following acute ethanol administration.  Mice (n = 12, 6
animals treated with saline, 6 treated with 4 g/kg ethanol) were
administered saline or ethanol and harvested 15 minutes, 1
hour, 2 hours, 4 hours, 8 hours and 24 hours following drug
administration and brain micropunch dissections performed for
protein isolation and Western blotting.
Exp. 7 – SGK1 phosphoSerine (S422) Levels following
chronic ethanol administration (ethanol
sensitization).  Animals (n=6-8/group) received one of four
treatments: saline-saline (SS), ethanol-saline (ES), saline-
ethanol (SE) or ethanol-ethanol (EE) (Table 1) with doses,
schedules and behavioral testing as with Exp. 3. Fifteen
minutes following drug administration, animals were harvested
and brain micropunch dissections performed for protein
isolation and Western blotting.
Table 1. Outline of experimental design for ethanol
sensitization.
Group Days 1-2 Days 3-13 Day 14
 Habituation Conditioning Activity Test
SS Saline Saline Saline
SE Saline Saline Ethanol 2.0 g/kg
EE Saline Ethanol 2.5 g/kg Ethanol 2.0 g/kg
ES Saline Ethanol 2.5 g/kg Saline
Exp. 8 – SGK1 and NDRG1 Basal Expression in Neurons
and Oligodendrocytes.  Mice (n = 2) were deeply
anesthetized with sodium pentobarbital (180 mg/kg i.p.) and
perfused transcardially with normal saline followed by 10 ml of
4% paraformaldehye. Brains were removed and post-fixed
overnight in 4% paraformaldehyde, cryoprotected in 30%
sucrose, and frozen using dry ice cooled 2-methylbutane.
Tissue was stored at -80 °C until immunohistochemistry was
performed.
Brain Micropunch Dissection
At designated times following ethanol or saline administration
in experiments 1, 2, 4, 6 and 7 brain tissue was collected.
Collection of brain tissue occurred exactly as described in
Kerns et al. [12]. The medial PFC dissection contained tissue
from dorsal and ventral anterior cingulate and some secondary
motor cortex.
RNA Isolation and Quantitative Real Time Polymerase
Chain Reaction (Q-rtPCR)
RNA was isolated from PFC tissue samples using the
RNeasy Protect Mini Kit (Qiagen, Valencia, CA, United States)
according to the manufacturer’s instructions. RNA
concentration and quality was assessed by Experion
automated electrophoresis (BioRad, Hercules, CA, United
States). cDNA was generated from 1 µg total RNA by reverse
transcription with the iScript CDNA kit (Bio-Rad, Hercules, CA,
United States) following the manufacturer’s instructions. Q-
rtPCR was performed using the iCycler iQTM system (Bio-Rad,
Hercules, CA, United States) according to the manufacturer’s
instructions for SYBR Green I-based detection. Quantification
of gene expression levels was determined based on the
threshold cycle for each well using the provided software and
all results were normalized to multiple reference genes using
Genorm as described in Vandesompele et al. [27]. Primers
used were as follows, Sgk1 (Forward-
CGTCAAAGCCGAGGCTGCTCGAAGC and Reverse-
GGTTTGGCGTGAGGGTTGGAGGAC), Sgk1.1 (Forward-
ATGCCAACATCCTGACCAA and Reverse-
TGCTGGCAATCTTCTGAATAAA), Glyceraldehyde 3-
phosphate dehydrogenase (Gapdh) (Forward-
TTCCAGTATGACTCCACTCACGG and Reverse-
TGAAGACACCAGTAGACTCCACGAC), protein phosphatase
2, regulatory subunit B, alpha (Ppp2r2a) (Forward-
ATCTCTCACCCTTGCCCTTT and Reverse-
CCCATTTTGTGTGCTTTCGT), ubiquitin-like domain
containing CTD phosphatase (Ublcp1) (Forward-
ATGACAGGGACAGGACAAGC and Reverse-
TACAATGACACCCGACTGGA), NDUFV1 NADH
dehydrogenase (ubiquinone) flavoprotein 1 (Ndufv1) (Forward-
GACCGTGCTAATGGACTTCG and Reverse-
GGCATCTCCCTTCACAAATC), nuclear receptor subfamily 3,
group C, member 1 (glucocorticoid receptor) (Nr3c1) (Forward-
AAGAGACAAACGAGAGTCCTTGG and Reverse-
GTGTCCGGTAAAATAAGAGGCTT, and Fkbp5 (Forward-
GCCGACTGTGTGTGTAATGC and Reverse-
CACAATACGCACTTGGGAGA).
Ethanol Regulation of Sgk1
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Blood collection and Radioimmunoassay (RIA)
One hour following ethanol or saline administration in Exp. 3
and Exp. 4, trunk blood was collected from individual mice.
Serum was isolated by centrifugation at 2500 x g for 15
minutes and stored at -80°C until RIA assay. A RIA containing
I125 labeled corticosterone (MP Biomedicals, Cleveland, OH,
United States) was performed according to the manufacturer’s
instructions.
Chromatin Immunoprecipitation (ChIP) Assay
Frontal poles from 8 D2 mice in Exp. 5 were combined to
make one individual sample and the ChIP analyses were
performed using the magnetic bead-based Chip-IT Express
Enzymatic kit following the manufacturer’s instructions for fresh
tissue (Active Motif, Carlsbad, CA, United States). Brieﬂy, the
tissue was cross-linked with 1% formaldehyde for 10 min,
sheared enzymatically for 2 hours and the chromatin
immunoprecipitated with the indicated antibodies: rabbit anti-
Glucocorticoid Receptor (sc-1004, Santa Cruz Biotechnology,
Santa Cruz, CA, United States) and rabbit anti-immunoglobulin
G (IgG) (2729, Cell Signaling, Danvers, MA, United States).
Following immunoprecipitation, the chromatin was eluted from
the magnetic beads, the cross-links were reversed, and the
protein was digested. Samples were then subjected to a DNA
clean-up step prior to Q-rtRCR using the QIAquick PCR
Purification Kit (Qiagen, Valencia, CA, United States) according
to the manufacter’s instructions. The resulting DNA fragments
in the range of 150 to 500 bp were analyzed by Q-rtRCR using
a pair of primers (Forward- ACCCCTGCTCCCTCTAACTC and
Reverse-GCGGAAATAAGTCTCTGCTCT) spanning the
glucocorticoid response element (GRE) in the Sgk1 promoter
region. For Q-rtRCR, SsoAdvanced™ SYBR® Green Supermix
(BioRad, Hercules, CA, United States) was used according to
the manufacturer’s instructions.
Western Blotting
While frozen, PFC tissue from animals in Experiments 6 and
7 was homogenized using a Dounce Tissue Homogenizer
(Fisher Scientific, Waltham, MA, United States) and then
suspended in Lithium Dodecyl Sulfate Loading Buffer
(Invitrogen, Grand Island, NY, United States) containing Halt
protease and phosphatase inhibitors (Thermo, Fisher Scientific,
Waltham, MA, United States) and sonicated. Western blotting
was performed using the XCell Surelock Mini-Cell kit
(Invitrogen, Grand Island, NY, United States) according to the
manufacturer’s instructions. SGK1 blots were probed with
rabbit anti-SGK1 (ab59337, AbCam, Cambridge, MA, United
States) and rabbit anti-GAPDH (ab9485, AbCam, Cambridge,
MA, United States). phospho-SGK1 (pSGK1) blots were
probed with rabbit anti-SGK1 phospho S422 (ab55281,
AbCam, Cambridge, MA, United States) (Experiments 6 and 7)
and goat anti-SGK1 phospho T256 (sc-16744, Santa Cruz
Biotechnology, Santa Cruz, CA, United States) (Exp. 6), then
stripped using Restore Western Blot Stripping Buffer (Thermo
Scientific, Rockford, IL, United States) and re-probed with
rabbit anti-SGK1 (ab59337, AbCam, Cambridge, MA, United
States). phospho-N-myc downstream-regulated 1 gene 1
(pNDRG1) blots were probed with rabbit anti-NDRG1 phospho
S330 (ab124713, AbCam, Cambridge, MA, United States),
then stripped and re-probed with rabbit anti-NDRG1 (ab63989,
AbCam, Cambridge, MA, United States). Blots were also
probed with the secondary antibodies IRDye goat anti-rabbit
680, IRDye goat anti-rabbit 800, and IRDye donkey anti-goat
800 antibodies (Li-cor Biosciences, Lincoln, NE, United States).
Western blot imaging was performed and images were
quantified using infrared imaging (Odyssey infrared imager, Li-
cor Biosciences, Lincoln, NE, United States) [28].
Immunohistochemistry
Tissue from Exp. 8 was cut into 30 micron-thick coronal
sections using a cryostat. Sections were permeabilized with
0.2% Triton X-100, and immunolabeled. Primary antibodies to
SGK1 (ab59337, AbCam, Cambridge, MA, United States),
NR3C1 (sc-1004, Santa Cruz Biotechnology, Santa Cruz, CA,
United States), NDRG1 (ab63989, AbCam, Cambridge, MA,
United States), MAP2 (ab5392, AbCam, Cambridge, MA,
United States), and CNPase (ab50739, AbCam, Cambridge,
MA, United States) were used. SGK1, NR3C1 and NDRG1
were visualized with Alexa Fluor 594 (A11012, Invitrogen,
Grand Island, NY, United States), and MAP2 and CNPASE
with Alexa Fluor 488 (A-11039, Invitrogen, Grand Island, NY,
United States) conjugated secondary antibodies. Lastly
sections were stained with DAPI to reveal their nuclei. The PFC
region of sections was imaged using a Zeiss LSM 700 confocal
laser scanning microscope. Images were extracted using ZEN
2011 (blue edition) imaging software (Carl Zeiss Microscopy,
LLC, Thornwood, NY, USA).
Statistics
Data were expressed as mean ± SEM and analyzed
parametrically. Data were analyzed with analysis of variance
(ANOVA) using appropriate between- and within subject
factors. All post hoc comparisons were made using Student
Newman-Keul’s test. Values of p < 0.05 were considered
statistically significant.
Results
Time course and dose response analysis of Sgk1 and
Sgk1.1 expression following acute ethanol
administration
Because our prior microarray studies and the studies of other
labs would have used probes that recognize cDNA regions
common to all Sgk1 isoforms (Figure 1a–c), we performed Q-
rtPCR studies to determine which Sgk1 isoform was
specifically regulated by ethanol, Sgk1.1 (Figure 1b) or Sgk1
(Figure 1c). Q-rtPCR was used to evaluate Sgk1 and Sgk1.1
levels 2, 4 and 8 hours following ethanol or saline
administration. Prior to performing these studies on ethanol, we
evaluated the effects of injection stress on Sgk1 expression as
a crtical control. We compared Sgk1 levels in the PFC of D2
mice basally (0 hour time point) to D2 mice harvested 2, 4 and
8 hours following saline injections. Saline injections did not
significantly alter Sgk1 levels at any time point compared to
basal Sgk1 levels (Figure S1). Because we saw no significant
Ethanol Regulation of Sgk1
PLOS ONE | www.plosone.org 4 August 2013 | Volume 8 | Issue 8 | e72979
effects of saline injections on Sgk1 expression, we did not
include a 0 hour time point in the remainder of our studies. In
evaluating Sgk1 levels, a two-way ANOVA showed an overall
effect of treatment, ethanol versus saline (F1,17 = 16.44, p <
0.01), but no overall effect of time and no significant treatment
x time interaction (Figure 2a). A one-way ANOVA showed a
significant effect of treatment (F5,22 = 4.51, p < 0.01) and post-
hoc analysis indicated that 4 hours following ethanol treatment
Sgk1 levels were significantly increased compared to all saline
treated animals and animals treated with ethanol 8 hours prior
to harvest (Figure 2a). In addition, Sgk1 levels were
significantly increased in animals harvested 2 hours following 4
g/kg ethanol administration compared to those harvested 8
hours following saline administration (Figure 2a). This indicates
that Sgk1 levels were significantly increased 2 and 4 hours
following 4 g/kg ethanol administration, returning to basal levels
by 8 hours.
A two-way ANOVA evaluating Sgk1.1 levels showed no
overall effect of treatment or time and no significant treatment x
time interaction (Figure 2b). However, there were significant
increases in Sgk1.1 mRNA at 8 hours following treatment in
both the ethanol and saline injected animals (one-way ANOVA,
F5,18 = 5.31, p < 0.01), suggesting a general response to the
injections themselves. These results suggest that Sgk1, not
Sgk1.1, is the ethanol responsive isoform of Sgk1.
To further evaluate which isoform of Sgk1 was ethanol
responsive, Q-rtPCR was used to evaluate Sgk1 and Sgk1.1
levels following an ethanol dose response assessment in which
animals were administered saline, 2 g/kg and 4 g/kg ethanol. In
evaluating Sgk1 levels, a one-way ANOVA showed a
significant effect of treatment (F2,18= 50.58, p < 0.01). Post-hoc
analysis indicated significant differences between 4 g/kg
ethanol versus saline, 2 g/kg ethanol versus saline and 4 g/kg
ethanol versus 2 g/kg ethanol indicating that Sgk1 is dose
dependently increased following ethanol administration (Figure
2c). Q-rtPCR analysis of Sgk1.1 transcript levels following
saline, 2 g/kg and 4 g/kg ethanol administration showed no
significant effects between the 3 groups by one-way ANOVA
(Figure 2d). Once again this indicated that Sgk1, not Sgk1.1, is
the ethanol responsive isoform.
Sgk1 levels following chronic ethanol sensitization
Prior microarray studies in our lab and others had identified
Sgk1 to be an acute ethanol responsive gene and we
confirmed this finding via Q-rtPCR (Figure 2a–d). However,
since we predicted that the HPA axis is involved in ethanol
regulation of Sgk1 and chronic ethanol exposure is known to
dysregulate the HPA axis, we performed studies to determine if
Sgk1 was regulated following chronic ethanol administration as
in locomotor sensitization. To answer this question, we
evaluated Sgk1 and Fkbp5 (another acute ethanol and
Figure 1.  Schematic of the SGK1 gene and N termini of Sgk1.1 versus Sgk1.  (a) White boxes indicate 5’ and 3’ untranslated
regions of Sgk1.1 and Sgk1, respectively; black boxes represent exons and the line represents introns. The SGK1 promoter
contains a GRE. (b) Exons of the N termini of Sgk1.1. (c) Exons of the N termini of Sgk1.
doi: 10.1371/journal.pone.0072979.g001
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glucocorticoid-responsive gene) levels acutely and chronically
following ethanol sensitization studies. One-way ANOVA
showed an overall effect of treatment on locomotor activity
(F2,21= 41.96, p < 0.01) (Figure 3a). Post-hoc analysis revealed
that ethanol-ethanol (EE) treated animals had significantly
greater locomotor activity compared to saline-ethanol (SE) and
saline-saline (SS) treated animals. In addition, SE treated
animals showed greater locomotor activity than SS treated
animals.
Q-rtPCR analysis of Sgk1 mRNA levels (4 hours post
injection) in these animals showed an overall significant effect
of treatment (one-way ANOVA, F2,9= 8.76, p < 0.01) (Figure
3b). Post-hoc analysis showed that Sgk1 levels were
significantly increased in animals treated acutely with ethanol
compared to SS and EE treated animals. Interestingly, Sgk1
levels did not differ between SS and EE treated animals. A
one-way ANOVA also identified significant differences in Fkbp5
levels (Figure 3c). There was an overall significant effect of
treatment (F2,9= 8.07, p = 0.01). Post-hoc analysis showed that
Fkbp5 levels were significantly increased in animals treated
acutely with ethanol compared to SS and EE treated animals.
Like Sgk1, Fkbp5 levels did not differ between SS and EE
treated animals. As additional controls, we also performed PCR
analysis of mRNA levels for the glucocorticoid receptor
(NR3c1) and the non-glucocorticoid responsive Sgk1.1 isoform
of Sgk1. A one-way ANOVA identified no significant differences
in Nr3c1 (Figure 3d) or Sgk1.1 (Figure S2) levels in SS, SE or
EE treated animals. These results indicated that Sgk1 and
Fkbp5, another ethanol responsive, glucocorticoid responsive
gene, are regulated by ethanol acutely, but not following
sensitization. Furthermore, Sgk1, not Sgk1.1 is again the
ethanol responsive isoform of Sgk1. The diminished Sgk1
response following ethanol sensitization does not appear to be
due to down-regulation of glucocorticoid receptor levels, at
least as assessed by Nr3c1 mRNA abundance.
Figure 2.  Acute ethanol time course and dose response analysis for Sgk1 and Sgk1.1 expression.  Q-rtPCR analysis of
Sgk1 and Sgk1.1. Panels show: (a) Sgk1 following 4 g/kg ethanol administration. * p < 0.05 versus all saline treated animals and 8
hour ethanol group, # p < 0.05 versus 8 hour saline group; (b) Sgk1.1 levels following 4 g/kg ethanol administration. * p < 0.05
versus ethanol and saline animals at 2 or 4 hours following ethanol administration, # p < 0.05 versus 2 hour ethanol group; (c)
Ethanol dose response for Sgk1 4 hours following ethanol administration. * p < 0.05 versus saline treated animals, # p < 0.05 versus
ethanol and saline treated animals (d) Sgk1.1 ethanol dose response at 4 hours.
doi: 10.1371/journal.pone.0072979.g002
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Corticosterone levels following ethanol sensitization
Sgk1 is a well-known glucocorticoid responsive gene and it is
known that animals and human alcoholics show a blunted HPA
axis while drinking and upon withdrawal. Because Sgk1 levels
were not regulated in animals following ethanol sensitization
despite normal levels of Nr3c1 expression, we hypothesized
that corticosterone levels may be blunted in animals chronically
treated with ethanol (EE animals). We sensitized animals to
ethanol and collected blood one hour following behavioral
testing to measure corticosterone levels across SS, SE, EE
and Ethanol-Saline (ES) treated animals. In evaluating the
behavioral response to ethanol, there was again evidence of
strong locomotor sensitization. A one-way ANOVA showed an
overall effect of treatment (F3,15= 159.67, p < 0.01) (Figure 4a).
Post-hoc analysis revealed that EE treated animals showed a
significantly greater locomotor response compared to SS, SE,
and ES treated animals. In addition, SE treated animals
showed a greater locomotor response compared to SS and ES
treated animals. In evaluating corticosterone levels at one hour
after injections of SS, SE, EE and ES mice, a one-way ANOVA
showed an overall significant effect of treatment (F3,15= 47.37, p
< 0.01) (Figure 4b). Post-hoc analysis revealed that SE
animals showed greater corticosterone levels than SS, EE and
ES indicating that corticosterone levels were blunted with
chronic ethanol treatment.
Effects of ADX on Sgk1 induction following ethanol
administration
Because Sgk1 was not induced in EE treated animals and
the corticosterone response to ethanol was also blunted in
these animals, we hypothesized that Sgk1 would not be
induced in ADX animals, animals lacking their adrenal glands,
the organ responsible for corticosterone release and the final
step in HPA axis activation. Q-rtPCR analysis of Sgk1 mRNA
levels at 4 hours following ethanol (4 g/kg i.p.) showed an
overall effect (two-way ANOVA, phenotype x treatment) of
phenotype (F1,22= 7.16, p < 0.05), treatment (F1,22= 11.05, p <
0.01) and a significant (phenotype x treatment) interaction
(F1,22= 5.31, p < 0.05) (Figure 5a). Post-hoc analysis of
phenotype indicated Sgk1 levels were significantly increased in
Figure 3.  Sgk1 mRNA expression following ethanol sensitization.  Behavioral sensitization followed by Q-rtPCR analysis of
Sgk1 and Nr3c1. Panels show: (a) Total locomotor activity (cm/10min.) for saline only (SS), acute ethanol (SE) and ethanol
sensitized (EE) groups. * p < 0.05 versus chronic saline (SS), # p < 0.05 versus acute ethanol (SE) (b) Sgk1 levels in SS, SE and
EE treated mice 4 hours following following saline (SS) or ethanol (SE, EE) treatment on day 14. * p < 0.05 versus SS and EE
treated animals (c) Nr3c1 levels in SS, SE and EE treated mice as in panel b.
doi: 10.1371/journal.pone.0072979.g003
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ethanol versus saline treated Sham animals, but not ADX
animals. Post-hoc analysis of treatment indicated significant
differences between ethanol, but not saline, treated Sham
versus ADX mice indicating that Sgk1 levels were blunted in
ADX mice following ethanol administration. We also evaluated
Sgk1.1 (Figure S3) and found no differences between Sgk1.1
levels in ADX versus Sham treated or saline versus ethanol
treated animals.
To ensure that animals were, in fact, adrenalectomized, we
evaluated corticosterone levels in ADX vs. SHAM animals. A
two-way ANOVA (phenotype x treatment) indicated an overall
effect of phenotype (F1,14= 52.22, p < 0.05), treatment (F1,14=
60.83, p < 0.01) and a significant (phenotype x treatment)
interaction (F1,14= 63.91, p < 0.05). Post hoc analysis revealed
that corticosterone levels were significantly greater in ethanol
treated SHAM animals versus saline treated SHAM animals,
saline treated ADX animals and ethanol treated ADX animals
(Figure 5b). Therefore, ADX mice did not experience increases
in corticosterone following ethanol administration and the
induction of Sgk1 in D2 mice may be due to HPA axis
activation and glucocorticoid signaling following acute ethanol
administration.
Chromatin Immunoprecipitation (ChIP) Assay
To test whether Sgk1 induction following ethanol
administration was due to glucocorticoid receptor (GR) binding
to the glucocorticoid response element (GRE) in the Sgk1
promoter, we performed a chromatin immunoprecipitation
(ChIP) assay in which we isolated chromatin from ethanol and
saline treated animals and conducted immunoprecipitation
Figure 4.  Serum corticosterone levels following ethanol sensitization.  Behavioral sensitization followed by corticosterone
quantification. Panels show: (a) Acute and sensitized locomotor response (cm/10 min.) following saline (SS, ES) or ethanol (EE, SE)
administration. * p < 0.05 versus SS and ES groups, # p < 0.05 versus SE, ES and SS groups; (b) Corticosterone levels 1 hour
following acute and chronic ethanol administration. * p < 0.05 versus SS, EE, and ES groups.
doi: 10.1371/journal.pone.0072979.g004
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studies using an anti-GR antibody and a control anti-IgG
antibody. A two-way ANOVA (antibody x treatment) showed an
overall effect of antibody (F1,8= 140.40, p < 0.01), treatment
(F1,8= 13.13, p < 0.01) and a significant (treatment x antibody)
interaction (F1,8= 5.85, p < 0.05). Post-hoc analysis revealed
that looking at samples in which GR immunoprecipitations were
performed, the level of Sgk1 promoter region bound to the GR
in ethanol treated samples was significantly greater than that
bound in saline treated samples. In samples in which IgG
immunoprecipitations were performed, there were no
Figure 5.  Effects of adrenalectomy on Sgk1 induction following ethanol administration.  (a) Q-rtPCR analysis of Sgk1 in
saline and ethanol treated SHAM versus ADX animals. * p < 0.05 versus saline treated SHAM animals and saline and ethanol
treated ADX animals; (b) Corticosterone levels 1 hour following acute ethanol administration. * p < 0.05 versus saline treated SHAM
animals and saline and ethanol treated ADX animals.
doi: 10.1371/journal.pone.0072979.g005
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significant differences between Sgk1 promotor region bound to
the IgG antibody in ethanol versus saline treated samples.
Additionally, looking at antibody effects within saline treated
animals, there was a significantly greater amount of Sgk1
promoter region bound to the GR antibody versus the IgG
antibody. Looking at antibody effects within ethanol treated
animals, there was a significantly greater amount of Sgk1
promoter region bound to the GR antibody versus the IgG
antibody (Figure 6). Therefore, we surmise that Sgk1 induction
in PFC following acute ethanol administration is due to
activation of the HPA axis and the subsequent binding of
corticosterone-activated GR to the GRE of the Sgk1 promoter.
Acute ethanol regulation of SGK1 protein abundance,
phosphorylation and functional activity
In addition to the transcriptional regulation studied above,
SGK1 is prominently regulated by multiple sites of protein
phosphorylation [22,29,30]. In particular, phosphorylation at
sites S422 and T256 are known to activate the kinase [30–32].
We therefore performed a detailed analysis on ethanol
regulation of SGK1 protein abundance and phosphorylation. A
time course (0.25-24 hours) Western blot analysis was
performed for SGK1 protein and phospho S422 (pS422) and
T256 (pT256) levels following ethanol (4 g/kg) versus saline
treatment. Given the prior documented increases in Sgk1
mRNA, we expected that we would find increased levels of
total SGK1 protein. Surprisingly, we found significant
decreases in total SGK1 protein in ethanol versus saline
treated animals 8 hours following ethanol administration
(student’s t-test, p < 0.05) (Figure 7a-b). At all other time points
studied (15 min, 1 h, 2 h, 4 h and 24 h), there were no
significant differences in SGK1 levels between saline and
ethanol treated animals (Figure S4a–f). We also compared
basal SGK1 levels to SGK1 levels 15 min and 8 h following
saline administration, time points where we found alterations in
SGK1 protein levels (8 h) or phosphorylated, active SGK1 (15
min). We found no differences in SGK1 levels at any of these
time points (Figure S5a-b).
Figure 6.  Chromatin immunoprecipitation (ChIP) quantification of glucocorticoid receptor (GR) bound to Sgk1 promoter
region.  DBA2/J mice were treated with saline or ethanol (4 g/kg) by i.p. injection and chromatin isolated 1 hour later from a frontal
pole dissection. Sgk1 promoter DNA was quantified by PCR following immunoprecipitation by control IgG or GR antibody. * p < 0.05
versus GR saline treated samples and IgG saline and ethanol treated samples, # p < 0.05 versus IgG saline and ethanol treated
samples.
doi: 10.1371/journal.pone.0072979.g006
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Studying the same time course described above for Western
blot analysis of total SGK1, we found a significant increase in
SGK1 pS422 and pT256 15 min. following ethanol treatment
(student’s t-test, p < 0.05) (Figure 8a–d). However there were
no differences between saline- and ethanol-treated animals
1-24 hours following drug treatment (Figure S6a–f). This
suggests a rapid activation of SGK1 by phosphorylation at both
S422 and T256 as early as 15 minutes following ethanol
treatment. We also compared basal SGK1 pS422 levels to
SGK1 pS422 levels 15 min and 8 h following saline
administration, time points where we found alterations in SGK1
protein levels (8 h) or phosphorylated, active SGK1 (15 min).
We found no differences in SGK1 pS422 levels at any of these
time points (Figure S7a-b).
Phosphorylation events should increase SGK1 kinase
activity. To support activation of SGK1, we studied
phosphorylation of NDRG1, a well-characterized downstream
target of phosphorylated SGK1 [33]. Western blot analysis
confirmed that ethanol treatment produced significant
increases in NDRG1-phospho S330 versus saline-treated
animals in PFC at 15 minutes following ethanol addition
(student’s t-test, p < 0.05) (Figure 9a-b).
Figure 7.  Total SGK1 protein following ethanol administration.  Western blot analysis of SGK1 8 hours following ethanol
(4g/kg) or saline treatment. Panels show: (a) Quantification of SGK1, (b) Representative Western blot. * p < 0.05 versus saline
treated animals.
doi: 10.1371/journal.pone.0072979.g007
Ethanol Regulation of Sgk1
PLOS ONE | www.plosone.org 11 August 2013 | Volume 8 | Issue 8 | e72979
Chronic ethanol regulation of SGK1 phosphorylation
We have shown that Sgk1, Fkbp5 and possibly other
glucocorticoid responsive genes were no longer regulated
following chronic ethanol administration (Figure 3a–d).
However, due to the disparate responses of Sgk1 mRNA and
protein levels (Figure 8a-b) with acute ethanol, we
hypothesized that SGK1 protein levels or phosphorylation
might show compensatory changes to the blunted HPA axis.
We therefore evaluated SGK1 pS422 levels following chronic
ethanol sensitization studies. There again was overall effect of
treatment on locomotor activity (one-way ANOVA, F3,27= 45.87
p < 0.01) (Figure 10a). Post-hoc analysis revealed that ethanol-
ethanol (EE) treated animals showed significantly greater
locomotor activity compared to saline-ethanol (SE), saline-
saline (SS) and ethanol-saline (ES) treated animals. In
addition, SE treated animals showed greater locomotor activity
than SS and ES treated animals. In evaluating SGK1 pS422
levels in these animals, there was an overall significant effect
of treatment on SGK1 pS422 levels (one-way ANOVA, F3,21=
8.75, p < 0.01) (Figure 10b,d). Post-hoc analysis showed that
SGK1 pS422 levels were significantly increased in animals
treated acutely with ethanol compared to SS and EE treated
animals. Interestingly, SGK1 pS422 levels were also
significantly elevated in ES treated animals compared to SS
and EE treated animals. SGK1 pS422 did not differ between
SS and EE treated animals. Total SGK1 levels did not differ
between SS, SE, EE and ES treated animals in any group 15
minutes following acute ethanol administration (Figure 10c-d).
SGK1 and NDRG1 Basal Expression in Neurons and
Oligodendrocytes
The studies on NDRG1 phosphorylation (Figure 9a-9b)
suggested that Sgk1 activation by ethanol might be occurring in
oligodendrocytes since NDRG1 is known to predominantly
expressed in that cell type within the central nervous system.
We performed immunohistochemistry to further decipher the
cell type(s) in which SGK1 may respond to ethanol and
transduce downstream signaling. We performed double
labeling experiments using neuronal (MAP2) and
oligodendrocyte (CNPase) markers in addition to NR3C1,
NDRG1 and SGK1 labeling to determine the cell types where
NR3C1, SGK1 and NDRG1 are expressed basally in the PFC
of D2 mice. We found that SGK1 and NR3C1 are expressed in
both neurons and oligodendrocytes in the PFC of D2 mice
Figure 8.  pSGK1 following acute saline and ethanol administration.  Western blot analysis of pS422 SGK1 and pT256 SGK1
at 15 minutes following ethanol (4g/kg) or saline treatment. Panels show: (a) Quantification of pS422 SGK1, (b) Representative
Western blot, c) Quantification of pT256 SGK1, and (d) Representative Western blot. * p < 0.05 versus saline treated animals.
doi: 10.1371/journal.pone.0072979.g008
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(Figure 11a,c,d,f). Whereas, NDRG1 is only expressed in
oligodendrocytes (Figure 11b,e). Neurons, cells positive for
MAP2, were also positive for SGK1 (Figure 11a) and NR3C1
(Figure 11c), but not NDRG1 (Figure 11b) at least as
detectable by immunofluorescence. Oligodendrocytes, cells
positive for CNPase, were also positive for SGK1 (Figure 11d),
NDRG1 (Figure 11e) and NR3C1 (Figure 11f). These results
suggest that SGK1 could regulate acute responses to ethanol
in both neurons and oligodendrocytes through glucocorticoid
signaling mechanisms. Additionally, NDRG1 signaling might
have a role as a downstream mediator of SGK1 responses to
acute ethanol in oligodendrocytes.
Figure 9.  NDRG1 phospho S330 following ethanol administration.  Western blot analysis of pS330 NDRG1 15 minutes
following ethanol (4g/kg) or saline treatment. Panels show: (a) Quantification of pS330 NDRG1, (b) Representative Western blot. * p
< 0.05 versus saline treated animals.
doi: 10.1371/journal.pone.0072979.g009
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Discussion
Prior studies in our laboratory and others suggest that
glucocorticoid signaling might play an important role in both
behavioral and brain gene expression responses to acute
ethanol [12,15,17]. Using genomic studies we previously
identified a significant over-representation of glucocorticoid-
responsive genes, including Sgk1, responding to acute ethanol
in PFC [12]. More recent studies from our laboratory showed
that inhibition of glucocorticoid signaling by adrenalectomy or
the glucocorticoid antagonist RU486 both impaired acute
ethanol-induced locomotor activation, suggesting that
glucocorticoid signaling may play a role in this behavioral
response [15]. Further, ADX altered the basal expression of
genes in PFC that included a significant number of previously
identified ethanol responsive genes [15]. Although there are
other conflicting reports about the role of glucocorticoids in
ethanol behaviors, recent studies elegantly document that
blockade of glucocorticoid signaling severely impairs escalated
ethanol consumption in an animal model of progressive ethanol
intake [34]. Furthermore, HPA axis dysregulation exists in
alcohol dependent patients and individuals with a familial
history of alcoholism [35,36]. Thus, disrupted HPA axis/
glucocorticoid signaling may contribute to the risk for
development of alcohol dependence. In this report, we have
provided mechanistic studies confirming that ethanol
modulates brain (PFC) gene expression in part through
glucocorticoid signaling and that alterations in this gene
expression regulatory loop occur with chronic exposure.
Prior studies in our laboratory and others identified the
glucocorticoid-regulated gene Sgk1 as an ethanol-responsive
gene [12,13,17]. Other investigators have described Sgk1
regulation following ethanol administration in whole brain [13]
and in striatum [17], but not in the PFC—a region known to be
important in glucocorticoid signaling [37]. Here we performed a
rigorous analysis of Sgk1 regulation in PFC by ethanol.
Although Sgk1 is the predominant transcript from the gene, an
alternative promoter produces the transcript Sgk1.1 that codes
for a more stable form of the SGK protein (Figure 1) [25].
However, ethanol only regulated expression of Sgk1 (Figure 2),
Figure 10.  pSGK1 following chronic saline and ethanol administration.  Western blot analysis of pS422 SGK1 15 minutes
following chronic saline (SS), acute ethanol (2g/kg) (SE), chronic ethanol (EE) or acute saline (ES) treatment. Panels show: (a)
Acute and sensitized locomotor response (cm/10 min.) following saline (SS, ES) or ethanol (EE, SE) administration. * p < 0.05
versus SS and ES groups, # p < 0.05 versus SE, ES and SS groups, (b) Quantification of pS422 SGK1, * p < 0.05 versus SS and
EE groups, # p < 0.05 versus SS and EE groups, c) Quantification of SGK1, and (d) Representative Western blot.
doi: 10.1371/journal.pone.0072979.g010
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Figure 11.  SGK1, NDRG1, and NR3C1 basal expression patterns in neurons and oligodendrocytes in the PFC of D2
mice.  NDRG1, NR3C1 and SGK1 were co-localized with the neuronal marker MAP2 and the oligodendrocyte marker CNPase.
DAPI staining was used as a nuclear marker (right columns). Panels show (from left to right): (a) SGK1 staining, MAP2 staining, co-
localization; (b) NDRG1 staining, MAP2 staining, co-localization; (c) NR3C1 staining, MAP2 staining, co-localization; (d) SGK1
staining, CNPASE staining, co-localization; (e) NDRG1 staining, CNPASE staining, co-localization; (f) NR3C1 staining, CNPASE
staining, co-localization. Scale bar equals 50 µm.
doi: 10.1371/journal.pone.0072979.g011
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which contains a glucocorticoid response element (GRE) in its
promoter [19,25]. We show for the first time, that ethanol
regulation of Sgk1 occurred via evoked glucocorticoid signaling
since adrenalectomy blocked ethanol induction of Sgk1
expression (Figure 5) and ethanol increased occupancy of
glucocorticoid receptor binding to the Sgk1 promoter in ChIP
assays (Figure 6). Ethanol regulation of Sgk1 transcription is
thus part of a HPA-PFC regulatory loop that could have an
important role in modulating the acute cellular response to
ethanol. The PFC is known to have high concentrations of
glucocorticoid receptors and to modulate HPA axis activity [37].
The PFC is also part of the mesolimbocortical dopamine
pathway that is involved in the rewarding properties of drugs of
abuse and is thought to contribute to the known interaction
between stress and ethanol consumption [38].
Ethanol regulation of Sgk1 versus Sgk1.1 may have
functional implications since the two isoforms have different
downstream targets. Sgk1 stimulates K+ channel activity and
regulates the function and availability of the epithelial sodium
channel (ENaC) [20,39,40]. Sgk1.1 is a brain specific isoform
of Sgk1 that has been shown to modulate the function of the
acid-sensing ion channel-1, the δENaC and M-current
[25,41,42].
Following chronic ethanol treatment to produce locomotor
sensitization, Sgk1 and serum corticosterone levels no longer
responded to ethanol treatment (Figures 3b, 4b). This provided
further evidence linking glucocorticoid signaling and ethanol
regulation of Sgk1. Furthermore, by dampening of the HPA
response to ethanol, a network of glucocorticoid-responsive
genes in PFC including Sgk1 and Fkbp5 have undergone an
adaptive response to chronic ethanol exposure. Although
additional future studies are needed to fully characterize the
response, our studies on SGK1 protein and phosphorylation
suggest the possibility that basal SGK1 activity might be
increased following chronic ethanol treatments during
locomotor sensitization, perhaps in compensation to the down-
regulated HPA axis responsiveness or other direct responses
to chronic ethanol.
While the studies here were not designed to prove or
disprove a role for Sgk1 in ethanol sensitization, our findings do
suggest testable hypotheses for future work. The dampening of
an acute ethanol and glucocorticoid-responsive gene network
(including Sgk1 and Fkbp5) in PFC could have important
implications for behavioral responses to chronic ethanol and
stress. Moreover, our results showing that basal SGK1
phosphorylation is increased following sensitization (Figure 10),
might directly affect ethanol-responsive locomotor activation.
Ongoing studies including more detailed evaluation of post-
translational changes in SGK1 following sensitization and direct
alteration of SGK1 levels or phosphorylation state are
necessary to definitively prove a link between Sgk1 and
behavioral responses to acute or chronic ethanol.
Other investigators have shown a similar trend in
corticosterone levels following chronic ethanol administration;
as corticosterone levels are blunted in male rats administered
ethanol following chronic operant self-administration, chronic
intragastric ethanol administration and rats and mice following
chronic i.p. injection [9,11,43,44]. However, this is the first work
relating HPA axis dampening (or “tolerance”) to changes in
PFC gene expression. Although other explanations exist for
lack of ethanol-responsiveness in Sgk1 following chronic
ethanol treatment, such as decreased glucocorticoid receptor
(GR) expression in PFC, the dampened corticosterone
response to ethanol (Figure 4) and ChIP results showing
increased GR binding to the Sgk1 promoter with acute ethanol
(Figure 6) are strong evidence linking the diminished Sgk1
response to corticosterone levels. There was some GR binding
to the GRE in the Sgk1 promoter in saline treated animals in
our ChIP studies. Although we habituated animals to injections
for two days prior to performing our experiments, this result
may reflect the stress of the injections or other environmental
factors on our experimental test day. Diminished GR (Nr3c1)
expression has been seen in the rat PFC following chronic
ethanol exposure [34], but our Q-rtPCR results showed no
significant changes in Nr3c1 mRNA levels in the PFC of SS,
SE vs EE treated animals (Figure 3d.). Although we did not
measure blood ethanol concentrations (BECs) in our studies,
prior studies with chronic ethanol showed corticosterone levels
were blunted despite elevated BECs [9,43]. Of possible
mechanistic importance, Roberts et al. reported that co-
treatment with the glucocorticoid antagonist RU486 blocked the
decrement in corticosterone during repeated ethanol treatment
for sensitization [11]. RU486 also partially blocked ethanol
locomotor sensitization in those experiments, although our prior
work has not replicated this finding possibly due to
methodological differences [15].
These studies also identified complex ethanol actions on
SGK1 expression at the level of protein expression and post-
translational modification (Figures 7-8). The
activation of SGK1 is triggered first by the phosphorylation of
S422 lying within the C-terminal hydrophobic motif of SGK1
followed by the phosphorylation of a threonine residue within
the T-loop of the kinase domain [29,30,32]. Mammalian target
of rapamycin (mTORC) was recently identified as the kinase
that phosphorylates SGK1 at Ser422, but there is debate as to
whether mTOR complex 1 or 2 is responsible for this
phosphorylation [45,46]. We found that phosphorylation of
SGK1 at S422 and T256 is transiently increased 15 minutes
following ethanol administration (Figure 8a. -d.) but that total
SGK1 protein abundance is significantly decreased as early as
6 hours (data not shown) and as late as 8 hours (Figure 7a. -b,
Figure S4) following ethanol administration. This is somewhat
paradoxical since Sgk1 mRNA abundance is increased at 2-4
hours after ethanol treatment (Figure 2a). The dissociation of
Sgk1 mRNA, total protein and phosphorylation state reinforces
the need for such concurrent studies for understanding the
mechanisms of ethanol action on such dynamically regulated
target as Sgk1.
The transient increase in SGK1 Ser422 phosphorylation
appears to be functional in that there is concomitant
phosphorylation of the known SGK1 substrate protein, NDRG1
(Figure 9a-b). NDRG1 is a well-known SGK1-specific substrate
minimally phosphorylated by other kinases and thought to be
predominantly expressed in oligodendrocytes in the central
nervous system [33,45,47]. Miyata et al. showed that a chronic
stress paradigm that elevated plasma corticosterone levels led
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to activation of the PDK1, SGK1, and NDRG1 pathway in
mouse oligodendrocytes [48]. There have been additional
alternative findings in the literature as to the cell type(s) where
SGK1 and NDRG1 mediate their effects. Okuda et al. identified
NDRG1 as mainly localized in oligodendrocytes in mouse
cerebrum [49]. Works examining SGK1 location in the human
brain of aged Alzheimer’s versus control patients documented
SGK1 location to be primarily neuronal [47]. However, other
work has found neurons, oligodendrocytes, and microglial cells,
but not astrocytes, were positive for SGK1 in the rat [50].
These alternate findings can be partially explained by species
and methodological differences.
Our immunofluorescence studies documented overlapping
basal expression patters for NDRG1, SGK1 and NR3C1 (GR).
These studies do not document the precise cell type
responsible for the mRNA and protein changes identified in this
work, However, we did document that NDRG1, SGK1 and GR
are all expressed in cells co-labeling with the oligodendrocyte
marker CNPase (Figure 11d–f). The increased NDRG1
phosphorylation after acute ethanol suggests that SGK1
activation by ethanol is occurring, at least in part, in
oligodendrocytes. However, since GR and SGK1 are also co-
expressed in cells labeling with the neuronal marker MAP2
(Figure 11a–c), there is also the possibility that ethanol
regulates Sgk1 expression in neurons as well. Future
quantitative immunohistochemistry or in situ hybridization
studies will be needed to more directly determine the cellular
site of ethanol regulation of Sgk1.
This study is the first description of this complex ethanol
regulation of Sgk1 mRNA, protein and phosphorylation. Similar
to our findings here, Piechota et al. showed Sgk1 mRNA is
significantly increased 2 hours following ethanol, morphine,
heroin and methamphetamine administration and that SGK1
protein is significantly decreased 4 hours following morphine
administration in the striatum. But those investigators did not
study SGK1 phosphorylation or protein regulation following
ethanol administration [17]. It is possible that ethanol triggers a
complex wave of signaling events leading to: 1) SGK1
activation by phosphorylation with subsequent phosphorylation
of NDRG1 and other targets; 2) increased Sgk1 transcription
by HPA axis activation and glucocorticoid action; and 3)
compensatory SGK1 protein degradation. Of note, Miyata et al.
showed that a chronic stress paradigm that elevated plasma
corticosterone levels similar to those found in depressed
individuals led to activation of the phosphatidylinositol 3-kinase
(PI3K)-3-phosphoinositide-dependent protein kinase (PDK1),
SGK1, and NDRG1 pathway with increases in both Sgk1
mRNA and SGK1 phosphorylation [48]. Thus, it is possible that
HPA axis activation is causal in both SGK1 activation and
increased transcription of the Sgk1 gene. Our findings of
increased SGK1 phosphorylation in sensitized animals,
however, would seem to dissociate HPA axis-derived
glucocorticoid signaling from the phosphorylation state of Sgk1.
Overall our findings support clinical reports showing stress
hypo-responsiveness in human alcoholics and provide
evidence for how HPA axis tolerance can alter ethanol
responses in brain stress/reward related regions such as PFC
[51–53]. While changes occurring at the endocrine level are
characterized, less defined are molecular changes in brain
stress/reward related regions that are mediated by HPA axis
tolerance. Our work here clearly indicates that future studies
are warranted to further characterize chronic ethanol regulation
of PFC expression networks, and determine whether
alterations in HPA-regulated genes such as SGK1 are
mechanistically linked to behavioral adaptations seen with
chronic ethanol exposure.
Supporting Information
Figure S1.  Sgk1 levels in the PFC of D2 mice basally (a 0
hour time point) and 2, 4 and 8 hours following saline
injections.
Saline injections did not significantly alter Sgk1 levels at any
time point compared to basal Sgk1 levels.
(TIF)
Figure S2.  Sgk1.1 levels following ethanol sensitization.
Sgk1.1 levels in SS, SE and EE mice.
(TIF)
Figure S3.  Q-rtPCR analysis of Sgk1.1.
Sgk1.1 in saline and ethanol treated SHAM versus ADX
animals.
(TIF)
Figure S4.  Time Course Western blot analysis of total
SGK1.
SGK1 was significantly decreased 8 hours following ethanol
versus saline administration (e). There were no significant
changes in SGK1 levels at any other time point (a–d, f). * p <
0.05 versus saline treated animals.
(TIF)
Figure S5.  Basal versus saline treated SGK1 levels.
There were no differences in SGK1 levels basally, 15 minutes
following saline injection or 8 hours following saline injection.
Panels show: (a) Quantification of SGK1, (b) Representative
Western blot.
(TIF)
Figure S6.  Time Course Western blot analysis of pSGK1
S422.
pSGK1 S422 was significantly increased 15 minutes following
ethanol versus saline administration (a). There were no
significant changes in pSGK1 S422 levels at any other time
point (b–f). * p < 0.05 versus saline treated animals.
(TIF)
Figure S7.  Basal versus saline treated SGK1 pS422 levels.
There were no differences in SGK1 pS422 levels basally, 15
minutes following saline injection or 8 hours following saline
injection. Panels show: (a) Quantification of SGK1 pS422, (b)
Representative Western blot.
(TIF)
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